Lakefront Biotherapeutics N.V.

LKFT

Healthcare|Biotechnology|BE

$33.45

-0.11 (-0.33%)

DCF Value

$50.09

Tangible Book / Share

$49.36

Graham Number

$90.77

Cash / Share

$45.26

Next Earnings Report

Nov 11, 2026

EPS est. -$0.83 · Revenue est. $7.5M

Financing Filings (last 12 months)

No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Nov 4, 2026 · GlobeNewsWire

Nov 2, 2026 · GlobeNewsWire

Oct 14, 2026 · GlobeNewsWire

Oct 13, 2026 · GlobeNewsWire

Oct 6, 2026 · GlobeNewsWire

Sep 29, 2026 · GlobeNewsWire

Sep 22, 2026 · GlobeNewsWire

Sep 15, 2026 · GlobeNewsWire

Sep 8, 2026 · GlobeNewsWire

Sep 8, 2026 · GlobeNewsWire

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Nov 4, 2026	6-K	Foreign issuer report	Document Index
Nov 2, 2026	6-K	Foreign issuer report	Document Index
Oct 20, 2026	6-K	Foreign issuer report	Document Index